Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000633:toxicity*; D002308:Cardiolipins / Q000008:administration & dosage / Q000633:toxicity; D003630:Daunorubicin / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity; D004317:Doxorubicin / Q000008:administration & dosage / Q000633:toxicity; D006321:Heart / Q000187:drug effects*; D007700:Kinetics; D008081:Liposomes / Q000008:administration & dosage*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009279:Naphthacenes / Q000008:administration & dosage / Q000633:toxicity
D000903:Antibiotics, Antineoplastic; D002308:Cardiolipins; D008081:Liposomes; D009279:Naphthacenes; D004317:Doxorubicin; D003630:Daunorubicin